M Ventures
Status
ACTIVE
Global HQ
Amsterdam, Netherlands
Countries of investment
- Germany
- Netherlands
- United States
Investment stages
- Seed
- Series A
- Series B
Industries
- Biotechnology
- Life Sciences
About
M Ventures is the corporate venture capital arm of Merck, investing globally in life sciences, healthcare, performance materials, and frontier technologies, with a dual focus on financial returns and strategic alignment.
M Ventures is the corporate venture capital arm of Merck, investing globally in life sciences, healthcare, performance materials, and frontier technologies, with a dual focus on financial returns and strategic alignment.
Investment Thesis
M Ventures (Merck Ventures) is the strategic corporate venture capital arm of Merck KGaA, investing in biotech and frontier technologies, including healthcare, life-science tools, electronics, and sustainability. With both strategic and financial objectives, the firm partners with visionary entrepreneurs to drive innovation toward commercial success, offering active involvement in its portfolio companies.
Manager's Experience
M Ventures, founded in 2009 as Merck KGaA’s strategic corporate venture arm, operates with a global team supporting biotech and technology startups through both strategic and financial investment mandates, having helped create over eighty companies from inception to exit.
Team
Hakan Goker – Managing Director
Javier Rodriguez – Head Technology Investments
Björn Kuhl – Head of Business Operations
Bauke Anninga – Investment Director
Portfolio
Actithera
Ambrx
Anavo
Artios
Asceneuron
Calypso Biotech
DISCO Pharmaceuticals
Enara Bio
EpiTherapeutics
F-Star Therapeutics
Forendo Pharma
FoRx Therapeutics
Future Fertility
Galecto Biotech
ImmuneBridge
Immunitas
Immunorizon
Inthera
iOmx Therapeutics
iOnctura
Kivu Bioscience